{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:52:59Z","timestamp":1793872379961,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.eprac.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T12:28:07Z","timestamp":1695990487000},"page":"960-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study"],"prefix":"10.1016","volume":"29","author":[{"given":"Shashank","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramesh","family":"Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Dharmalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Vadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Keshavamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Mechanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2023.08.016_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101377","article-title":"Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease","volume":"48","author":"Chang","year":"2022","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.016_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049286","article-title":"Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India","volume":"8","author":"Nigam","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.eprac.2023.08.016_bib3","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J\u00a0Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.016_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.amjcard.2007.03.107","article-title":"Postprandial hyperglycemia\/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor","volume":"100","author":"O\u2019Keefe","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.eprac.2023.08.016_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.016_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NT.0000000000000512","article-title":"Dietary guidelines for Americans, 2020\u20132025: understanding the scientific process, guidelines, and key recommendations","volume":"56","author":"Snetselaar","year":"2021","journal-title":"Nutr Today"},{"key":"10.1016\/j.eprac.2023.08.016_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/advances\/nmy130","article-title":"A\u00a0global review of food-based dietary guidelines","volume":"10","author":"Herforth","year":"2019","journal-title":"Adv Nutr"},{"issue":"6","key":"10.1016\/j.eprac.2023.08.016_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","article-title":"Human postprandial responses to food and potential for precision nutrition","volume":"26","author":"Berry","year":"2020","journal-title":"Nature medicine"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.016_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8102","article-title":"Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes","volume":"2","author":"Mendes-Soares","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2023.08.016_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.eprac.2023.08.016_bib11","first-page":"578","article-title":"Effect of personalized nutrition on health-related behaviour change: evidence from the Food4me European randomized controlled trial","volume":"46","author":"Celis-Morales","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eprac.2023.08.016_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management","volume":"40","author":"Bern\u00e1","year":"2020","journal-title":"Liver Int"},{"issue":"185","key":"10.1016\/j.eprac.2023.08.016_bib13","first-page":"283","article-title":"inventors; Twin Health Inc, assignee. Precision treatment with machine learning and digital twin technology for optimal metabolic outcomes","volume":"11","author":"Hadley","year":"2021","journal-title":"United States Patent US"},{"key":"10.1016\/j.eprac.2023.08.016_bib14","doi-asserted-by":"crossref","first-page":"108952","DOI":"10.1109\/ACCESS.2020.2998358","article-title":"Digital twin: enabling technologies, challenges and open research","volume":"8","author":"Fuller","year":"2020","journal-title":"IEEE Access"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2023.08.016_bib15","first-page":"71","article-title":"26-OR: metabolic benefits beyond glycemic control with artificial intelligence, internet of Things, and whole-body digital twin: initial six months results of a randomized control trial","author":"Joshi","year":"2022","journal-title":"Diabetes"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2023.08.016_bib16","first-page":"71","article-title":"4-LB: remission of type 2 diabetes and improvement in metabolic markers with the twin precision treatment technology (TPT)\u2014a multicenter, randomized, controlled trial","author":"Shamanna","year":"2022","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.eprac.2023.08.016_bib17","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.eprac.2023.03.067","article-title":"Abstract# 1413498: whole body digital twin technology for remission of T2DM and normalization of glycemic and fatty liver parameters: 1 Year intent to treat analysis of the prospective randomized controlled clinical trial","volume":"29","author":"Joshi","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2023.08.016_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2022.118630","article-title":"Impact of benign sample size on binary classification accuracy","volume":"211","author":"Mimura","year":"2023","journal-title":"Expert Syst Appl"},{"issue":"11","key":"10.1016\/j.eprac.2023.08.016_bib19","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s13300-020-00931-w","article-title":"Reducing HbA1c in type 2 diabetes using digital twin technology-enabled precision nutrition: a retrospective analysis","volume":"11","author":"Shamanna","year":"2020","journal-title":"Diabetes Therapy"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.016_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/cd20-as01","article-title":"Standards of Medical Care in Diabetes\u20142020 abridged for primary care providers","volume":"38","year":"2020","journal-title":"Clinical Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.016_bib21","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1097\/01.hjh.0000835932.52938.30","article-title":"Correlation of Diabetes remission with reductions in blood pressure and cardiovascular risk scores: results of six months of randomised trial with digital twin technology","volume":"40","author":"Shamanna","year":"2022","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1016\/j.eprac.2023.08.016_bib22","article-title":"Remission of T2DM by digital twin technology with reduction of cardiovascular risk: interim results of randomised controlled clinical trial","volume":"43","author":"Shamanna","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eprac.2023.08.016_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jhep.2018.07.013","article-title":"An internet-based approach for lifestyle changes in patients with NAFLD: two-year effects on weight loss and surrogate markers","volume":"69","author":"Mazzotti","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.eprac.2023.08.016_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023597","article-title":"Post hoc analyses of surrogate markers of nonalcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study","volume":"9","author":"Vilar-Gomez","year":"2019","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.eprac.2023.08.016_bib25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT Trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2023.08.016_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076161","article-title":"Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"8","author":"Hashiba","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.eprac.2023.08.016_bib27","doi-asserted-by":"crossref","DOI":"10.2196\/14802","article-title":"Lifestyle intervention enabled by mobile technology on weight loss in patients with nonalcoholic fatty liver disease: randomized controlled trial","volume":"8","author":"Lim","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"issue":"10","key":"10.1016\/j.eprac.2023.08.016_bib28","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2337\/dc10-0856","article-title":"Fatty Liver Subgroup of the Look Ahead Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes","volume":"33","author":"Lazo","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23005438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:15:27Z","timestamp":1761516927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23005438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1530891X23005438"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.08.016","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}